Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation. [electronic resource]
- Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie Jan 2019
- 806-814 p. digital
Publication Type: Journal Article
1950-6007
10.1016/j.biopha.2018.09.086 doi
Animals Carcinoma, Hepatocellular--drug therapy Chalcone--analogs & derivatives Dose-Response Relationship, Drug Enzyme Inhibitors--pharmacology Hep G2 Cells Humans Liver Neoplasms--drug therapy Male Mice Neovascularization, Pathologic--drug therapy Phosphorylation--drug effects Pigments, Biological--pharmacology Quinones--pharmacology p38 Mitogen-Activated Protein Kinases--antagonists & inhibitors